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a  b  s  t  r  a  c  t
Background:  As a  major  zoonotic  pathogen,  characterization  of  the  infectivity  and  pathogenicity  of  Coxiella
burnetii is  essential  to understand  Q-fever  epidemiology.
Objectives: We  want  to  extend  a recently  published  human  dose  response  model  based  on  experimental
challenge  of  young  adult  males  to  include  other  age  groups  and  both  genders.  Additionally,  we can
estimate  the spatial  distribution  of  exposure  based  on  observed  outbreak  data.
Methods: Dose  response  assessment  based  on  human  challenge,  is extended  by  including  outbreak  data,
using  location  of  cases  as a proxy  for exposure.  This  allows  estimation  of  the  inﬂuence  of  age  and  gender
on  the probability  of developing  symptoms  of acute  respiratory  illness.
Results:  In an  outbreak  in  Switzerland,  in  1983,  exposure  to C. burnetii  was shown  to depend  stronglyutbreak
ose response
xposure estimates
on  distance  from  the source.  The  susceptibility  of  males  to  develop  Q-fever  decreases  with age,  while  in
females,  middle-aged  women  appear  to have  the  lowest  risk.
Conclusions:  The  published  dose  response  model  for  Q-fever,  based  on  experimental  challenge  of a  small
group  of human  volunteers,  has  been  updated  with  data  from  a well  studied  outbreak.  Infectivity  esti-
mates  remain  high,  and even  low  doses  (of 10 or fewer  organisms)  cause  a  high  risk  of  illness.
©  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-NDntroduction
From 2007 to 2010, an epidemic of Q-fever in the Netherlands
aused more than 3000 cases, due to Coxiella burnetii spreading
rom infected goat farms (Schimmer et al., 2010). Such large num-
ers of notiﬁed cases imply that a much higher number of infections
ust have occurred (van der Hoek et al., 2012), and that exposure
ay  have been widespread. A recently published dose response
elationship estimated the dose required for ﬁfty percent of the
xposed population to become infected (infd50) at 1.5 bacteria
0.75–38.7 95% credible interval (CI)), indicating high infectivity
f C. burnetii via aerosol exposure (Brooke et al., 2013). These
redictions were based on experimental challenge of adult male
olunteers. Outbreak data from the Netherlands indicate that both
ge and gender may  affect the risk of developing acute Q-fever
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(Schimmer et al., 2008). This is reﬂected in the published litera-
ture where males are 1.5–2.5 times as likely to be notiﬁed than
females (van der Hoek et al., 2010; Karagiannis et al., 2009; Maurin
and Raoult, 1999) and incidence increases with age and peaks in the
50–60 year age group (Schimmer et al., 2008; Maurin and Raoult,
1999). Therefore, the effects of age and gender on susceptibility for
infection and acute illness must be quantiﬁed.
For every symptomatic case of Q-fever, there are many infec-
tions that are not notiﬁed. Published estimates of the incidence
of seroconversion to notiﬁed cases ranges from 1.5 (Maurin and
Raoult, 1999) to 62.5 (Kampschreur et al., 2013). During the out-
break in the Netherlands, a serological study in a high incidence
region quantiﬁed the rate ratio between seroconversion in blood
donors to the number of notiﬁed cases in the outbreak area at 12.6
seroconversions for each notiﬁed case (van der Hoek et al., 2012).
However, the ratio of seropositives to notiﬁed cases may  depend
on the dose. Human challenge study results indicate that at lower
doses individuals can become infected but, once infected, they are
more likely to remain asymptomatic (Brooke et al., 2013).
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).


























































Numbers exposed, infected and ill. Eight cases with missing age or gender informa-
tion  were excluded.
Age Total Sero-positive Combined Ill
IgM+ IgX+ IgM+ IgX+
0–19 601 3 8 33 38 30
20–39 630  10 26 92 108 82
40–59  428 10 28 48 66 38
>  60 253 6 15 28 37 22
1912 29 77 201 249 172
Data overview: the numbers exposed (village residents), numbers screened and
numbers classiﬁed as infected by serology: IgM positive (IgM+), IgM and IgG positive
(IgX+). Also shown, right hand side: screened numbers combined with population R.J. Brooke et al. / E
To quantify the effects of age and gender, a study should include
ndividual patient data with information about infection status, ill-
ess status, age, and gender, as well as the applied dose. It would be
mpossible to implement such a design as a clinical trial. However,
 well studied outbreak could provide a natural experiment, where
ealth effects can be studied in a deﬁned population exposed to C.
urnetii. In the fall of 1983 a large outbreak of Q-fever took place
n the Val de Bagnes, in the canton of Valais in Switzerland. Dur-
ng this outbreak 191 symptomatic cases and 224 asymptomatic
ases were identiﬁed (Dupuis et al., 1987). This Swiss outbreak is
he ﬁrst documented point source outbreak of Q-fever as well as
ne of the most comprehensively studied outbreaks (Dupuis et al.,
987). Effort was undertaken to identify asymptomatic infections
y means of a serosurvey. Serological screening of a major fraction
approximately 50%) of the exposed population identiﬁed many
symptomatic cases; demographic characteristics were collected
y questionnaire, completed by all surveyed subjects. Direct obser-
ations of exposure are not available from this outbreak. However,
ecause this was a point source outbreak, distance from the source
ould be used as a proxy for dose. We  will show how this allows us
o quantify exposure by village.
Combined epidemiological and serological data from the Swiss
utbreak can be used to update the dose response model based
n the human challenge study, to include age and gender in order
o allow predictive studies of infection and illness in humans after
xposure to C. burnetii.
ethods
On October 8 and 9, 1983 there was a market for alpine sheep
n the soccer ﬁeld of the Val de Bagnes high school in Le Châble,
n the canton of Valais in Switzerland. The animals were brought
own from the hills, auctioned and then sent to the new owners,
bout half of which were in different districts outside the study
rea. At the market and adjacent slaughterhouse 30 sheep were
laughtered (a known risk event), which was believed to be the pri-
ary source of C. burnetii in the valley. The outbreak was  identiﬁed
fter eight concurrent hospitalized acute Q-fever cases had been
otiﬁed. A large scale screening program was started 4–8 weeks
ater, after the peak of the epidemiological curve, approximately
–3 months after the sheep market had been held. The community
as approached and everyone in the valley was asked to provide
 blood sample as well as ﬁll in an epidemiological survey. The
lood samples were screened for IgM phase 1 and 2 and IgG phase
 and 2 using indirect micro-immunoﬂuorescence (IF) as described
n the original outbreak report (Dupuis et al., 1987). The IF test for
gM tested for the presence of phase 1 and 2 antibodies at levels of
:20, 1:40, 1:80 and 1:160 while IgG was tested at levels of 1:40,
:80 and 1:160.
Archived original data records from the outbreak were elec-
ronically entered at the regional hospital in Sion, Switzerland and
ross-checked for errors, see Table 2. The data consist of birth year,
ender, village of residence and location data, illness status, and
erological markers. A symptomatic case is deﬁned as any indi-
idual living in the valley, who was notiﬁed to the public health
uthorities and who had a known date for the onset of illness after
he date of the animal market. Note that this includes any notiﬁed
ases among the screened population.
Among screened subjects who were not notiﬁed cases, infection
ay  be identiﬁed by serology. Two different categories of infected
ubjects were deﬁned, based on serum antibody titers measured
rom the time of exposure until one year later:
IgM positive (IgM+) at least one observed titer of 1:20 or higher,
for IgM phase I or IgM phase II.data, including numbers notiﬁed with acute Q-fever, as used for the dose response
assessment.
• IgM positive or IgG positive (IgX+) either IgM positive, or at least
one observed titer of 1:40 or higher for IgG phase I or IgG phase
II.
So that IgX+ is a more inclusive deﬁnition of infection than IgM+,
see Fig. 1 (Table 1).
A negative screened case is an individual who is not a notiﬁed
case and does not have a serological proﬁle indicative of infection.
Note that any resident of the valley who  was not a notiﬁed case
could have been asymptomatically infected. Demographic data for
the entire valley were obtained from the 1980 census data from the
Swiss Federal Statistics Ofﬁce (S.F.S. Ofﬁce, 2013).
Though dose was  not quantiﬁed during the outbreak, the loca-
tion of a resident can be used as a proxy for exposure. Increasing
distance from the source of contamination is associated with
decreasing exposure (Schimmer et al., 2010) as is suggested when
viewing attack rates by village as a function of Euclidian distance
from the presumed source (Fig. 2). Spatial kernel calculations used
the locations of the center of gravity for each village, using build-
ing density as a proxy for population density. Required data were
obtained from OpenStreetMap (www.openstreetmap.org) hosted
by GeoFabrik (www.geofabrik.de) on November 11, 2013. The
buildings in the valley were cross referenced with survey maps,
which were gathered during the original outbreak, to ensure that
all buildings were accounted for. Increase in population since 1980
has been predominantly in the valley’s ski resort with no large
development elsewhere in the valley. The Swiss national coordi-
nate system CH1903 (SRID/EPSG 21781) was  used for all spatial
maps and calculations.
Based on the literature and exploratory logistic regression,
effects of age and gender were included for illness but not for infec-
tion. The beta-Poisson dose response model for infection assumes
that a volume V inhaled from a suspension of pathogens of con-
centration c results in exposure to a discrete random number
of bacteria that is Poisson distributed with an expected value of
cV. Heterogeneity in the host–pathogen interaction is taken into
account by assuming a beta distributed conditional probability of
infection (Teunis and Havelaar, 2000). The resulting dose response
relation is
Pinf(cV |˛, ˇ) = 1 − 1F1(˛,  ˛ + ˇ; −cV) (1)
where 1F1 is a conﬂuent hypergeometric function (Abramowitz and
Stegun, 1965) and (˛, ˇ) are the parameters of the beta distribution
describing heterogeneity. Infection may remain asymptomatic: a
fraction of those infected may  develop symptoms of acute illness,
which may  again depend upon dose (Teunis et al., 1999). To account
for a dose dependent probability of symptoms we used the condi-
tional dose response model proposed by Teunis et al. deﬁning the
























iig. 1. Fraction infected and symptomatic. Fraction of the screened population cla
raction of the exposed population with symptoms of acute Q-fever (Symp).
robability of illness among those that are infected (Teunis et al.,
999).
ill|inf(cV |, ) = 1 − (1 + cV)− (2)
ith shape parameter  and scale parameter  (Teunis et al., 1999).
urther, it is assumed that the scale parameter  is stratiﬁed by age
nd gender as
og([i, j]) = a,s[i, j] + s[j]; i = 1, 2, 3, 4; j = 1, 2 (3)
here a,s[i, j] represent scale parameters for age category i (0–19,
0–39, 40–59, 60 years and older), and gender j (female and male);
s[j] is a gender speciﬁc offset term.
The spatial variation in exposure is modelled using a distance
ernel that is proportional to a bivariate normal distribution with







he mode at (x0, y0) is the estimated location where the highest
xposure occurred, presumably near the source of the outbreak.
nisotropic exposure can occur because the two  axes (x, y) may
e different, and the orientation of the axes may  be adjusted by the
orrelation coefﬁcient x,y. The logarithm of the dose then changes
ith location as
ig. 2. The proportion symptomatic decreases with increasing distance from the putativ
odel with a signiﬁcant (p < 0.0001) distance term. To indicate village size, 95% binom
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where log(dose) is the (log) of the dose: the average number of
bacteria inhaled by a subject at location (X, Y), h0 is the peak dose
at location (x0, y0).
Serological screening was not performed on all inhabitants of
the valley. Therefore the probability of sampling an infected sub-
ject depends on the probability that that subject is screened. The
probability of sampling an asymptomatically infected subject, Pinf





where Pinf,smpl is the fraction of asymptomatically infected
(not notiﬁed) subjects in the screened population of a village,
Nscrn,i/Npop,i is the fraction screened in any village i. For notiﬁed
cases we  assume that they do not depend on screening: the proba-
bility of observing a notiﬁed case is the same for screened subjects
and subjects who were not screened.Simultaneous estimation of parameters of the dose response
relations for infection and illness including the effects of age and
gender, and the spatial relation between village location and dose,
was done by means of Markov chain Monte Carlo (MCMC).
e source of exposure. The regression line is the ﬁtted values of a logistic regression
ial conﬁdence intervals are included except for villages with no cases, which are
 reader is referred to the web version of this article.)
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Table  2
Outbreak data by village.
Village Population Screened Symptomatic
All <20 All <20
Bruson 247 160 (65%) 24 2 (0.8%) 0
Le  Châble 401 289 (72%) 81 25 (6%) 5
Champsec 169 60 (36%) 24 8 (5%) 1
Le  Cotterg 173 120 (69%) 28 6 (3%) 1
Fionnay 140 2 (1%) 1 1 (0.7%) 0
Fontenelle 70 6 (9%) 3 0 (0%) 0
Le  Fregnoley 32 3 (9%) 0 2 (6%) 0
Lourtier 482 302 (63%) 71 19 (4%) 7
Le  Martinet 26 15 (58%) 6 1 (4%) 0
Medieres 117 6 (5%) 6 0 (0%) 0
Montagnier 299 127 (42%) 29 31 (10%) 2
La  Montoz 43 5 (12%) 0 3 (7%) 0
Prarreyer 203 91 (45%) 31 10 (5%) 4
Sarreyer 343 136 (40%) 17 3 (0.9%) 0
Le  Sappey 63 4 (6%) 4 0 (0%) 0
Versegeres 203 128 (63%) 49 19 (9%) 2
Verbier 772 176 (23%) 163 2 (0.3%) 0
Villette 316 290 (92%) 64 40 (13%) 8



























Estimated maximum dose and location of peak exposure for two deﬁnitions of
infection by serology.
Peak exposure Latitude Longitude
eh0 x0 (km) y0 (km)
IgM+ 0.16 (0.13–0.25) −0.31 (−3.67 to 4.14) 0.94 (−3.62 to 4.48)




eata from outbreak in Val de Bagnes, Switzerland: Population exposed, population
creened, and numbers notiﬁed with symptoms of acute Q-fever. For the screened
opulation, total numbers and those younger than 20 years are shown.
The model was implemented in JAGS (v3.4.0) and run using rjags
v3-13) in R (v3.0.3), for source code see online supplement. Based
n slow convergence of the human challenge model (Brooke et al.,
013), three chains were run for 107 iterations, after checking for
onvergence thinned chains (thinning factor 104) were merged and
he resulting 3000 parameter samples used for further calculations.
alculations of spatial coordinates were performed with Quantum
IS (v1.8).
esults
The coverage of screening in all villages is 1920 out of 4099 (47%)
cross all age groups, see online supplement, Fig. S1. Among chil-
ren, the proportion screened is an impressive 93% of all 10–15
ear olds. Details on the numbers screened and infected are given
n Table 1. The screened population is equally divided between men
664/1319 adults, 322/601 children) and women (647/1319 adults,
79/601 children). Median age of the included adult population was
0 years, mean age of 43 years, and range 20–99 years. Of the com-
ined village population of 4099, 172 (3.5%) were notiﬁed cases,
ee Table 2.
Initially exploratory analysis was performed, using logistic
egression, to test if age, gender, and distance along the two  main
xes (North–South and East–West) were predictive for infection
r illness. Two interaction terms were included: age × gender and
atitude × longitude. Backward selection for infection, interaction
erms ﬁrst, found no signiﬁcant predictors for infection, see Table 3.
able 3
ogistic regression results.
Parameter Infection coefﬁcients 
(Intercept) −2.83 (−3.08 to 
Gender – 
Age  – 
Latitude – 
Longitude – 
Gender × age – 
Latitude × longitude – 
LM logistic regression coefﬁcients with 95% conﬁdence intervals of screened population
ffects on infection while illness GLM indicated signiﬁcant effects for both age and gendeMedian estimates of peak exposure (average number of infectious bacteria) and
spatial coordinates of the exposure peak, and 95% interval.
Backward selection for illness, interaction terms ﬁrst, found that
both interaction terms were signiﬁcant predictors for illness.
The full model therefore includes a spatial kernel to estimate
exposure by village (location). Infection dose response is assumed
independent of age and gender, but given infection, dose response
for illness depends on age (category) and gender.
The exposure estimates by village show a clear dependence
on distance from the source, see Fig. 4. The spatial kernel esti-
mate for peak exposure is low, around 1 infectious bacterium
or smaller, while the location of peak exposure is offset from
the approximate location of the animal market where the source
was located (Table 4). The contours of exposure are shown in
Fig. 4.
The estimated 50% infectious dose of the combined outbreak and
human challenge data is 0.71 (95% CI 0.70–0.74), independent of the
deﬁnition of infection. The estimated dose causing 50% probability
of (acute) illness increases with increasingly inclusive deﬁnitions
of infection as explained below (Fig. 5). The IllD50 also depends on
age and sex: in children it is highest; in female subjects the IllD50
increases with age, but in females above 60 it decreases again. In
males the IllD50 increases from age 20 onwards.
For children who may  have been in a nursery or at school at the
time of exposure, the location of their residence is not a suitable
proxy for exposure as the animal market was  held on the ﬁeld next
to the school. Therefore, in an initial analysis, all subjects under
20 years of age (601) were excluded, leaving 1319 screened sub-
jects. Subsequently, all children were allocated to the village of
Montagnier, near the location where the exposure occurred. The
estimated doses by village, and the estimated infectivites and ill-
ness risks remained the same. Therefore, here only the results of
the combined analysis including all children, are shown.
The size of the infected population is based on the results of sero-
logical screening. To investigate the sensitivity of the model to the
screening criteria, two  different deﬁnitions of infection were used
(see Methods section). Using the more inclusive deﬁnition leads to
a higher number of infected subjects, and thus the estimated doses
increase (Fig. 3). Given the observed numbers of acute cases, the
50% infectious dose does not depend on the criteria for infection, but
the dose required for 50% illness does, because the same numbers
of acute symptomatic cases appear to occur at higher estimated
doses (Fig. 5).
Illness coefﬁcients
−2.60) −2.52 (−3.34 to −1.74)
1.61 (0.60–2.64)
0.00 (−0.01 to 0.02)
0.02 (−0.13 to 0.18)
−0.30 (−0.65 to 0.05)
−0.03 (−0.05 to 0.00)
0.27 (0.03–0.51)
 20 years and older. Backward selection of parameters indicated no age or gender
r.
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Fig. 3. Exposure estimates by village for different deﬁnitions of infection. Estimated me
graphs, illustrating how both IgM+ and IgX+ produce the same ordering of doses, but wit
Cotterg  0 km (IgM+); 2.3 km (IgX+), and distance to Fionnay 9 km (IgM+); 11.4 km (IgX+).
Fig. 4. Spatial distribution of exposure. Based on the distance kernel, infections
deﬁned as IgM+ or IgX+. The location of highest exposure is offset from the animal
market (indicated by “+” at (x, y) = (0, 0)) see Table 4. Predicted doses were obtained
by averaging from a posterior sample of parameter estimates, and shown as contours
of  equal individual exposure (average number of infectious bacteria inhaled by an
individual at location (x, y)).dian dose and 95% range. Villages are sorted by dose estimated for IgM+ in both
h different magnitudes. For reference: distance from estimated source location to
DiscussionTo our knowledge this is the ﬁrst quantiﬁcation of C. burnetii
exposure during an outbreak using epidemiological data and dose
response modelling. It is also the ﬁrst characterization of the effect
of age and gender on human susceptibility to infection and illness.
Fig. 5. Boxplot of illness dose 50% by age and gender groups. (a) Age groups females;
(b)  age groups males. From left to right are the illd50% for the Swiss outbreak by
age  category with white boxes representing the IgX+ scenario and the grey boxes
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ompared to the published studies on C. burnetii dose response
elations (Tamrakar et al., 2011), the present results are better
rounded in empirical data. Due to the inclusion of subjects from
 wide range of ages, and both sexes, these new results are more
eneralizable than the published dose response relations in exper-
mentally challenged young adult males (Brooke et al., 2013).
The risk of acute illness appears to depend on age and gender,
ig. 5. Males tend to be slightly more susceptible than females, who
ave a higher illD50%. In males, the illD50 increases with age, which
s contrary to Dutch literature that identiﬁed the age group between
0 and 60 years as having the highest incidence. Females between
0 and 60 years of age appear to have a higher illD50 than younger
omen, but in women older than 60 the susceptibility increases
gain. The gender difference may  be due to a protective effect of the
emale sex hormone beta-estradiol, which controls host responses
o C. burnetii (Leone et al., 2004). Studies in blood donors show
qual numbers of seropositives in both genders implying Q-fever
nfectivity may  be equal in males and females, but the occurrence
f clinical symptoms depends upon gender (Maurin and Raoult,
999).
The comprehensive nature and quality of the 1983 Swiss out-
reak data makes this analysis possible. Nonetheless, quantifying
he number of asymptomatic (non-notiﬁed) infections remains dif-
cult because these can only be observed using invasive methods
ike sampling of blood, which is especially difﬁcult given the limited
ime available.
Different inclusion criteria for infected cases were tested,
ecause of observations that some notiﬁed cases during the Dutch
utbreak had only IgG positive serology after three months from
nset of symptoms (Teunis et al., 2013). The infection estimates in
he more inclusive scenario (IgX+), provide higher doses that we
onsider more realistic than the highly selective scenario (IgM+).
he IgM+ scenario is based on diagnostic protocols for acute Q-fever
here high speciﬁcity is desired to reduce the probability of false
ositives. Both scenarios lead to similar age patterns of the illD50%,
nd to similar spatial exposure patterns.
Comparing the previously published dose response relations to
he present results shows the effect of updating the dose response
odel with the Swiss outbreak data. The infD50% of the original
tudy is 1.18 (95% CI 0.76–40.2) and the updated model changes this
stimate to 0.71 (0.70–0.74). The median value is slightly lower, and
he estimate is less uncertain than the previously reported estimate,
ee online supplement, Figs. S2 and S3.
The estimated location of the highest exposure is close to the
nown location of the animal market, supporting the assumption
hat this is the source that caused the outbreak. The small offset
rom the exact location of the market may  be due to the effects
f wind in the valley. A Western wind, following the direction of
he valley South-Eastwards, is known to have been the predomi-
ant wind direction during the exposure period. In the Netherlands
istance has been shown to be a predictor for the illness risk
Schimmer et al., 2010; van Leuken et al., 2013). Studies work-
ng on environmental effects on aerosol dispersion could provide
dditional information regarding the relationship between aerosol
xposure, environmental factors and infection rates.
The current analysis does not include any environmental deter-
inants regarding the dispersion of airborne particles in the valley.
he spatial distribution of exposure has been determined from the
patial distribution of infected and symptomatic subjects only. The
esults are consistent with the assumption that the slaughter house
nd market are the main source of exposure but there might be
esidual exposure resulting from the herding of infected animals
rom the ﬁelds. The wind in the valley may  affect the dispersion;
ltitude may  also play a factor as villages higher up the sides of the
alley might be less likely to be exposed compared to villages at
he base of the valley. It is interesting that the estimated spatialics 11 (2015) 1–6
dispersion parameters (x and y, in Table 4) are of the same order
of magnitude as parameter values used in atmospheric dispersion
modelling Hanna et al. (1982).
The results from this study may  be used in risk studies, to trans-
late exposure estimates into risk of infection and acute respiratory
illness, and to deﬁne acceptable levels of exposure near environ-
mental sources of C. burnetii.
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